Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic β cells and rat INS-1 cells

Department of Physiology and Neuroscience, Department of Pediatrics, Department of Cell Biology and 6 Department of Pharmacology, New York University School of Medicine, New York, NY, USA Department of Physiological Chemistry and Centre for Biomedical Genetics, University Medical Center Utrecht, Universiteitsweg 100, 3584CG Utrecht, The Netherlands BIOLOG Life Science Institute, PO Box 107125, D-28071 Bremen, Germany

[1]  L. Mayorga,et al.  Calcium-induced Acrosomal Exocytosis Requires cAMP Acting through a Protein Kinase A-independent, Epac-mediated Pathway* , 2006, Journal of Biological Chemistry.

[2]  F. Lezoualc’h,et al.  cAMP-Binding Protein Epac Induces Cardiomyocyte Hypertrophy , 2005, Circulation research.

[3]  R. Biondi,et al.  Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells. , 2005, Molecular biology of the cell.

[4]  T. Shibasaki,et al.  PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. , 2005, Physiological reviews.

[5]  YoshihikoSaito,et al.  Enhanced Functional Gap Junction Neoformation by Protein Kinase A–Dependent and Epac-Dependent Signals Downstream of cAMP in Cardiac Myocytes , 2005 .

[6]  N. Mochizuki,et al.  Enhanced Functional Gap Junction Neoformation by Protein Kinase A–Dependent and Epac-Dependent Signals Downstream of cAMP in Cardiac Myocytes , 2005, Circulation research.

[7]  F. Ashcroft.  ATP-sensitive potassium channelopathies: focus on insulin secretion. , 2005, The Journal of clinical investigation.

[8]  M. Harbeck,et al.  A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic β cells , 2005, The Journal of physiology.

[9]  J. Holst,et al.  Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. , 2005, Diabetes.

[10]  G. Holz.  New Insights Concerning the Glucose-dependent Insulin Secretagogue Action of Glucagon-like Peptide-1 in Pancreatic β-Cells , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[11]  O. Chepurny,et al.  Diabetes Outfoxed by GLP-1? , 2005, Science's STKE.

[12]  T. Shibasaki,et al.  Integration of ATP, cAMP, and Ca2+ signals in insulin granule exocytosis. , 2004, Diabetes.

[13]  T. Shibasaki,et al.  Interaction of ATP Sensor, cAMP Sensor, Ca2+ Sensor, and Voltage-dependent Ca2+ Channel in Insulin Granule Exocytosis* , 2004, Journal of Biological Chemistry.

[14]  M. Magnuson,et al.  Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine. , 2004, American journal of physiology. Endocrinology and metabolism.

[15]  H. Matsui,et al.  Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic β-cells , 2003 .

[16]  O. Chepurny,et al.  Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus. , 2003, Current medicinal chemistry.

[17]  A. Wittinghofer,et al.  Ligand-mediated Activation of the cAMP-responsive Guanine Nucleotide Exchange Factor Epac* , 2003, Journal of Biological Chemistry.

[18]  S. Døskeland,et al.  cAMP Analog Mapping of Epac1 and cAMP Kinase , 2003, Journal of Biological Chemistry.

[19]  J. Bos.  Epac: a new cAMP target and new avenues in cAMP research , 2003, Nature Reviews Molecular Cell Biology.

[20]  A. Wittinghofer,et al.  Communication between the Regulatory and the Catalytic Region of the cAMP-responsive Guanine Nucleotide Exchange Factor Epac* , 2003, Journal of Biological Chemistry.

[21]  J. Bos,et al.  Epac-selective cAMP Analog 8-pCPT-2′-O-Me-cAMP as a Stimulus for Ca2+-induced Ca2+ Release and Exocytosis in Pancreatic β-Cells* , 2003, The Journal of Biological Chemistry.

[22]  L. Eliasson,et al.  SUR1 Regulates PKA-independent cAMP-induced Granule Priming in Mouse Pancreatic B-cells , 2003, The Journal of general physiology.

[23]  J. Bos,et al.  Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the β2-adrenergic receptor , 2003, The Journal of cell biology.

[24]  G. Holz,et al.  Amplification of exocytosis by Ca2+‐induced Ca2+ release in INS‐1 pancreatic β cells , 2003, The Journal of physiology.

[25]  J. Bryan,et al.  cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets. , 2002, Diabetes.

[26]  S. Døskeland,et al.  A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK , 2002, Nature Cell Biology.

[27]  J. Gromada,et al.  Sulfonylurea Receptor Type 1 Knock-out Mice Have Intact Feeding-stimulated Insulin Secretion despite Marked Impairment in Their Response to Glucose* , 2002, The Journal of Biological Chemistry.

[28]  P. Light,et al.  Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism. , 2002, Molecular endocrinology.

[29]  Xiaodong Cheng,et al.  Cell Cycle-dependent Subcellular Localization of Exchange Factor Directly Activated by cAMP* , 2002, The Journal of Biological Chemistry.

[30]  O. Chepurny,et al.  Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic β-cell lines for use in transplantation , 2002, Cell and Tissue Research.

[31]  T. Shibasaki,et al.  Critical Role of cAMP-GEFII·Rim2 Complex in Incretin-potentiated Insulin Secretion* , 2001, The Journal of Biological Chemistry.

[32]  K. Jakobs,et al.  A new phospholipase-C–calcium signalling pathway mediated by cyclic AMP and a Rap GTPase , 2001, Nature Cell Biology.

[33]  O. Chepurny,et al.  cAMP‐regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+‐induced Ca2+ release in INS‐1 pancreatic β‐cells , 2001, The Journal of physiology.

[34]  M. Nitabach,et al.  Is the molecular composition of K(ATP) channels more complex than originally thought? , 2001, Journal of molecular and cellular cardiology.

[35]  B. Hille,et al.  Ionic channels of excitable membranes , 2001 .

[36]  W. Ding,et al.  Involvement of Calmodulin in Glucagon‐Like Peptide 1(7‐36) Amide‐Induced Inhibition of the ATP‐Sensitive K+ Channel in Mouse Pancreatic β‐Cells , 2001, Experimental physiology.

[37]  J. Habener,et al.  Expression of cAMP-regulated guanine nucleotide exchange factors in pancreatic beta-cells. , 2000, Biochemical and biophysical research communications.

[38]  J. Henquin,et al.  Triggering and amplifying pathways of regulation of insulin secretion by glucose. , 2000, Diabetes.

[39]  Yasuhiro Sunaga,et al.  cAMP-GEFII is a direct target of cAMP in regulated exocytosis , 2000, Nature Cell Biology.

[40]  M. Wakui,et al.  cAMP-independent decrease of ATP-sensitive K+ channel activity by GLP-1 in rat pancreatic β-cells , 2000, Pflügers Archiv.

[41]  A. Wittinghofer,et al.  Mechanism of Regulation of the Epac Family of cAMP-dependent RapGEFs* , 2000, The Journal of Biological Chemistry.

[42]  M. Hussain,et al.  Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element. , 2000, Diabetes.

[43]  Y. Jan,et al.  Regulation of ATP‐sensitive potassium channel function by protein kinase A‐mediated phosphorylation in transfected HEK293 cells , 2000, The EMBO journal.

[44]  S. Seino,et al.  PKA‐mediated phosphorylation of the human KATP channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation , 1999, The EMBO journal.

[45]  J. Habener,et al.  cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37). , 1999, The Journal of biological chemistry.

[46]  A M Graybiel,et al.  A family of cAMP-binding proteins that directly activate Rap1. , 1998, Science.

[47]  A. Wittinghofer,et al.  Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP , 1998, Nature.

[48]  D. Mears,et al.  Glucagon Induces Suppression of ATP-sensitive K+ Channel Activity Through a Ca2+/Calmodulin-dependent Pathway in Mouse Pancreatic β-Cells , 1998, The Journal of Membrane Biology.

[49]  C. Nichols,et al.  Membrane phospholipid control of nucleotide sensitivity of KATP channels. , 1998, Science.

[50]  J. Ruppersberg,et al.  PIP2 and PIP as determinants for ATP inhibition of KATP channels. , 1998, Science.

[51]  J. Holst,et al.  Glucagon-Like Peptide 1(7-36) Amide Stimulates Exocytosis in Human Pancreatic β-Cells by Both Proximal and Distal Regulatory Steps in Stimulus-Secretion Coupling , 1998, Diabetes.

[52]  L. Eliasson,et al.  Protein kinase A‐dependent and ‐independent stimulation of exocytosis by cAMP in mouse pancreatic B‐cells , 1997, The Journal of physiology.

[53]  F. Ashcroft,et al.  The essential role of the Walker A motifs of SUR1 in K‐ATP channel activation by Mg‐ADP and diazoxide , 1997, The EMBO journal.

[54]  J. Inazawa,et al.  Reconstitution of IKATP: An Inward Rectifier Subunit Plus the Sulfonylurea Receptor , 1995, Science.

[55]  J. Habener,et al.  Activation of a cAMP-regulated Ca-Signaling Pathway in Pancreatic -Cells by the Insulinotropic Hormone Glucagon-like Peptide-1 (*) , 1995, The Journal of Biological Chemistry.

[56]  J. Clement,et al.  Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. , 1995, Science.

[57]  D. Scharp,et al.  cAMP-enhancing agents “permit” stimulus-secretion coupling in canine pancreatic islet β-cells , 1994, The Journal of Membrane Biology.

[58]  F. Ashcroft,et al.  Two types of potassium channel regulated by ATP in pancreatic B cells isolated from a type-2 diabetic human , 1993, Pflügers Archiv.

[59]  J. Habener,et al.  Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37) , 1993, Nature.

[60]  J. Habener,et al.  Signal transduction crosstalk in the endocrine system: pancreatic beta-cells and the glucose competence concept. , 1992, Trends in biochemical sciences.

[61]  Susan S. Taylor,et al.  Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates. , 1990, The Journal of biological chemistry.

[62]  B. Ribalet,et al.  ATP mediates both activation and inhibition of K(ATP) channel activity via cAMP-dependent protein kinase in insulin-secreting cell lines , 1989, The Journal of general physiology.

[63]  P. Rorsman,et al.  Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic β-cells , 1986, Pflügers Archiv.

[64]  C. Tei,et al.  Cyclic AMP/cAMP‐GEF pathway amplifies insulin exocytosis induced by Ca2+ and ATP in rat islet β‐cells , 2006, Diabetes/metabolism research and reviews.

[65]  Burns C Blaxall,et al.  Phospholipase C epsilon modulates beta-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy. , 2005, Circulation research.

[66]  M. Lohse,et al.  Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line. , 2005, The Journal of biological chemistry.

[67]  G. Holz.  Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. , 2004, Diabetes.

[68]  A. Wittinghofer,et al.  Structure and regulation of the cAMP-binding domains of Epac2 , 2003, Nature Structural Biology.

[69]  H. Matsui,et al.  Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells. , 2003, American journal of physiology. Endocrinology and metabolism.

[70]  A. Smrcka,et al.  Phospholipase C(epsilon): a novel Ras effector. , 2001, The EMBO journal.

[71]  M. Wakui,et al.  cAMP-independent decrease of ATP-sensitive K , 2000 .

[72]  H. Hidaka,et al.  Pharmacology of protein kinase inhibitors. , 1992, Annual review of pharmacology and toxicology.

[73]  C B Wollheim,et al.  Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. , 1992, Endocrinology.

[74]  M. Hussain,et al.  Exendin-4 as a Stimulator of Rat Insulin I Gene Promoter Activity via bZIP / CRE Interactions Sensitive to Serine / Threonine Protein Kinase Inhibitor Ro 31-8220 , 2002 .